Ligand design strategies are critical in controlling the structure, stability, and reactivity of metal complexes in inorganic chemistry. Through rational modification of ligand frameworks, chemists can tailor electronic…
secretase enzyme (BACE1) was found to be higher than that of standard. De novo ligand design generated best suitable derivative of the selected lead by iterations. Both compound
screening (both target-based and ligand-based), molecular dynamics simulation, toxicity prediction and rational ligand design in order to search for potential inhibitors to human papillomavirus E6 oncoprotein. We also…
virtual combinatorial libraries and interactive designer of compounds. The developed consensus models (CM) for predicting stability constants (log K) of the metal ion –organic ligand complexation are integrated in…
involved in agonist activation of the 4 receptors. This raises difficult problems in ligand design of agonists and antagonists for these 4 receptors which are involved in many diseases, including
tumor tissues, while it is highly restricted in normal tissues. Various targeting moieties or ligands against tumor cell-specific receptors have been immobilized on the surface of nano-particulate carriers ... vitro…
enhanced efficacy and synergy and reduction in toxicities can be expected. The design of such ligands requires careful consideration of the three dimensional organization of the multiple pharmacophores so that…
micromolar SARS-CoV antiviral efficacy using an integrated approach that exploits both ligand and structure-based therapeutic design techniques. Metabolic stability and pharmacokinetic evaluation of one of these two…
reduce undesirable side effects. We demonstrate this new approach to drug design with the development of multivalent ligands for the treatment of neuropathic pain, the most ubiquitous disease ... motor impairment. We…
phosphonate ligands to modify the nanoparticle (NPs) surface has attracted strong interest in the last years for the design of highly functional hybrid materials. Here, we applied a methodology ... synthesize…
pharmacophores for receptors that are found in the disease state. For example, we have designed ligands that have potent agonist activities at mu and delta opioid receptors, and potent antagonist ... studies in animal…
design safe, next-generation drugs against asthma and inflammation. In the present study, crystal structure analysis was performed to distinguish the PDE4b and PDE4d selectivity on the basis of ligand
introduced here is fundamentally centered around NK1R nonpeptide opposing ligands and the likely utilization of SP/NK1R framework in designated radionuclide growth treatment
approaches to drug design and development. In particular it is possible to design multivalent ligands that can address 2 or more targets for the disease state, all in a single ... approach for two different diseases. In…
large number of RNA-binding agents have already been identified, the rational design of synthetic molecules that would be specific for a particular RNA structure remains extremely difficult. Recently, this ... devoted a…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.